1h Free Analyst Time
The in-vitro diagnostics (IVD) market is forecasted to grow by USD 28.8 billion during 2024-2029, accelerating at a CAGR of 4.6% during the forecast period. The report on the in-vitro diagnostics (IVD) market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing geriatric population, chronic and infectious diseases, demand for personalized medicine, and new product launches.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.
The in-vitro diagnostics (IVD) market is segmented as below:
By Product Type
- Reagents and kits
- Instruments
- Others
By Technology
- Immunoassay
- Molecular diagnostics
- Clinical chemistry
- Hematology
- Others
By Application
- Oncology
- Cardiology
- Autoimmune diseases
- Neurology
- Others
By End-user
- Hospitals and clinics
- Research institutes
- Diagnostics laboratories
- Others
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
The report on the in-vitro diagnostics (IVD) market covers the following areas:
- In-Vitro Diagnostics (IVD) Market sizing
- In-Vitro Diagnostics (IVD) Market forecast
- In-Vitro Diagnostics (IVD) Market industry analysis
The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
2 Market Analysis
3 Market Landscape
4 Market Sizing
5 Historic Market Size
6 Qualitative Analysis
7 Five Forces Analysis
8 Market Segmentation by Product Type
9 Market Segmentation by Technology
10 Market Segmentation by Application
11 Market Segmentation by End-user
12 Customer Landscape
13 Geographic Landscape
14 Drivers, Challenges, and Opportunity/Restraints
15 Competitive Landscape
16 Competitive Analysis
17 Appendix
List of Exhibits
Executive Summary
The following companies are recognized as the key players in the global in-vitro diagnostics (IVD) market: Abbott Laboratories, Agilent Technologies Inc., ARKRAY Inc., Becton Dickinson and Co., BGI Genomics Co. Ltd., Bio Rad Laboratories Inc., BioMerieux SA, Charles River Laboratories International Inc., Danaher Corp., DiaSorin SpA, F. Hoffmann La Roche Ltd., Grifols SA, Illumina Inc., Merck KGaA, QIAGEN N.V., Quest Diagnostics Inc., QuidelOrtho Corp., Siemens Healthineers AG, Sysmex Corp., and Thermo Fisher Scientific Inc..Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is global adoption of advanced treatment solutions."
According to the report, one of the major drivers for this market is the increasing geriatric population, chronic and infectious diseases.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Abbott Laboratories
- Agilent Technologies Inc.
- ARKRAY Inc.
- Becton Dickinson and Co.
- BGI Genomics Co. Ltd.
- Bio Rad Laboratories Inc.
- BioMerieux SA
- Charles River Laboratories International Inc.
- Danaher Corp.
- DiaSorin SpA
- F. Hoffmann La Roche Ltd.
- Grifols SA
- Illumina Inc.
- Merck KGaA
- QIAGEN N.V.
- Quest Diagnostics Inc.
- QuidelOrtho Corp.
- Siemens Healthineers AG
- Sysmex Corp.
- Thermo Fisher Scientific Inc.
